Product Name | MF | CAS | Details |
---|
BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride | C41H44Cl2N4O5 | 2691796-83-3 | Details |
Aldometanib | C27H43Cl2N2.I | 2904601-67-6 | Details |
TCA1 | C16H13N3O4S2 | 864941-32-2 | Details |
PI-55 | C13H13N5O | 1122579-42-3 | Details |
PBRM1-BD2-IN-7 | C16H15ClN2O | 2819989-68-7 | Details |
IM-93 | C21H28N4O2 | 1173657-73-2 | Details |
Butofilolol | C17H26FNO3 | 58930-32-8 | Details |
DEPTOR-IN-1 | C24H16Cl2FNO4 | 2615911-12-9 | Details |
p38-α MAPK-IN-4 | C17H13BrN2O | 2396754-57-5 | Details |
Anticancer agent 43 | C14H9FN2O3S2 | 2470015-35-9 | Details |
MFI8 | C16H18ClNO | 694488-83-0 | Details |
Cannabicitran | C21H30O2 | 31508-71-1 | Details |
CS1 | C16H12O3 | 1448009-94-6 | Details |
NBC 19 | C24H26BCl3N2O2 | 2068818-75-5 | Details |
Phentolamine acetate | C19H23N3O3 | 249607-96-3 | Details |
SLF1081851 | C21H33N3O | 2763730-97-6 | Details |
Itaconate-alkyne | C13H18O4 | 2454181-83-8 | Details |
Msr-Ratio | C18H14O3S | 2290635-22-0 | Details |
Modoflaner | C23H10F12IN3O2 | 1331922-53-2 | Details |
IAB15 | C15H14F3NO2 | 2987139-91-1 | Details |
Prexasertib mesylate | C19H23N7O5S | 1234015-55-4 | Details |
BPN-15477 | C12H10ClN5 | 1971086-99-3 | Details |
SARS-CoV-2-IN-13 | C13H8Cl2N2O4 | 56961-10-5 | Details |
PBRM1-BD2-IN-3 | C14H11ClN2O | 2819989-58-5 | Details |
H-D-Phe-Pip-Arg-pNA dihydrochloride | C27H37ClN8O5 | 62354-65-8 | Details |
ZINC194100678 | C10H13N5O | 1995025-05-2 | Details |
Thunbergol | C20H34O | 25269-17-4 | Details |
Bcl-xL antagonist 2 | C21H16N4O3S2 | 1235032-75-3 | Details |
SK1- I hydrochloride | C17H28ClNO2 | 2366222-05-9 | Details |
Zuclopenthixol dihydrochloride | C22H27Cl3N2OS | 58045-23-1 | Details |
JNJ-1289 | C16H12N4OS | 792898-18-1 | Details |
CT52923 | C23H25N5O4S | 205256-55-9 | Details |
BRD-8899 | C17H22N4O3S | 1404437-50-8 | Details |
MRK-623 | C20H17FN4O | 461449-78-5 | Details |
Metallo β-lactamase ligand 1 | C7H9NO5S | 1087784-71-1 | Details |
FFN 102 mesylate | 1883548-92-2 | Details |
Etoxadrol | C16H23NO2 | 28189-85-7 | Details |
UNC-CA359 | C18H14ClN3O2 | 2676156-05-9 | Details |
UCPH-102 | C21H18N2O2 | 1229591-56-3 | Details |
SKF83959 | C18H20ClNO2 | 80751-85-5 | Details |
GAT228 | C22H18N2O2 | 1446648-15-2 | Details |
MKK7-COV-9 | C18H16N4O2 | 2283355-59-7 | Details |
BTX161 | C15H16N2O3 | 2052301-24-1 | Details |
(E)-Guanabenz | C8H8Cl2N4 | 60329-03-5 | Details |
Cycrimine | C19H29NO | 77-39-4 | Details |
(R)-Fadrozole | C14H13N3 | 102676-87-9 | Details |
α-Glucosidase-IN-2 | C17H11N3O2S2 | 2699784-18-2 | Details |
PCC0208017 | C19H20F3N7 | 2623158-64-3 | Details |
Antibacterial agent 105 | C14H9N3O5 | 2364493-24-1 | Details |
Nur77 modulator 1 | C28H25N5O2S | 2469975-55-9 | Details |
Org 25543 | C24H32N2O4 | 363628-88-0 | Details |
GSK-1482160 | C14H14ClF3N2O2 | 1001389-72-5 | Details |
DL-Willardiine | C7H9N3O4 | 19772-76-0 | Details |
BTK-IN-16 | 2883232-92-4 | Details |
MIF-IN-2 | C14H10ClN3O4 | 2756410-57-6 | Details |
VU0420373 | C15H11FN2O | 38376-29-3 | Details |
Antitumor agent-68 | C17H11NO2 | 2566497-96-7 | Details |
CXCR2 antagonist 8 | C14H13N3O5 | 182498-30-2 | Details |
N-(4-bromo-2-chlorophenyl)-5-chloro-2-hydroxybenzamide | C13H8BrCl2NO2 | 1098360-68-9 | Details |
Atg4B-IN-2 | C21H30O3 | 2765008-88-4 | Details |
MT189 | C21H18FN3O2 | 1885900-35-5 | Details |
FTO-IN-8 | C19H23ClN2O2 | 2640366-38-5 | Details |
BCR-ABL1-IN-1 | C18H12F3N3O2 | 1488090-21-6 | Details |
DDX3-IN-2 | C20H23N5O | 1919828-81-1 | Details |
Tuberculosis inhibitor 3 | C21H22F6N4O3S | 2219325-28-5 | Details |
Aquacycline | C22H25ClN2O9 | 423769-22-6 | Details |
ERCC1-XPF-IN-2 | C15H13Cl2NO3 | 1808986-37-9 | Details |
VPC-18005 | C15H17N3O3S | 2242480-48-2 | Details |
Bromodomain inhibitor-10 | C20H20N4O3 | 1870849-58-3 | Details |
Isoetharine hydrochloride | C13H22ClNO3 | 50-96-4 | Details |
BCL6-IN-6 | C27H31FN6O2S | 2408882-54-0 | Details |
(R)-BDP9066 | C20H24N6 | 2284549-25-1 | Details |
KN1022 | C21H22N6O5 | 205255-11-4 | Details |
ADTL-EI1712 | C22H18Cl2N4O2S2 | 2414916-45-1 | Details |
DSS30 | C16H14ClNO3S2 | 883027-32-5 | Details |
NLRP3-IN-11 | C17H17ClN4O2 | 2769040-91-5 | Details |
TAS 205 | C27H36N6O4.H2O | 1584160-52-0 | Details |
SARS-CoV-2-IN-15 | C14H9ClF3NO2 | 1580-42-3 | Details |
IAA65 | 2987139-96-6 | Details |
Diamthazole | C15H23N3OS | 95-27-2 | Details |
Guanoxabenz hydrochloride | C8H9Cl3N4O | 23256-40-8 | Details |
Pixantrone hydrochloride | C17H20ClN5O2 | 175989-38-5 | Details |
TGFβ-IN-1 | C19H18N2O | 883560-84-7 | Details |
Mab Aspartate Decarboxylase-IN-1 | C16H11N3O3 | 2755712-12-8 | Details |
Isofezolac | C23H18N2O2 | 50270-33-2 | Details |
Anti-inflammatory agent 15 | C17H20N2S | 474516-87-5 | Details |
MDH1-IN-1 | C21H25NO4 | 2143463-31-2 | Details |
Izuforant | C12H12BrN7 | 1429374-83-3 | Details |
Alisertib sodium | C27H21ClFN4NaO4 | 1028486-06-7 | Details |
MAT2A inhibitor 3 | C16H14ClN3O | 2439271-82-4 | Details |
Myt1-IN-1 | C16H15ClN4O2 | 2719749-02-5 | Details |
Tubulin inhibitor 27 | C21H19NO4 | 184579-57-5 | Details |
α-Glucosidase-IN-4 | C19H14O4 | 2410538-67-7 | Details |
Benzonitrile, 4-[[5-cyclopropyl-3-methyl-1-[(methylsulfonyl)methyl]-1H-pyrazol-4-yl]oxy]-2,6-dimethyl- | C18H21N3O3S | 936345-34-5 | Details |
AChE/BChE/MAO-B-IN-1 | C20H24N2O2 | 2416910-82-0 | Details |
EM127 | C14H18ClN3O3 | 1886879-71-5 | Details |
Acetophenazine | C23H29N3O2S | 2751-68-0 | Details |
Metallo-β-lactamase-IN-8 | C13H11ClN2O4S | 1610537-25-1 | Details |
Chitin synthase inhibitor 2 | C20H19N3O3 | 2416338-24-2 | Details |
Antibacterial agent 26 | C19H17N5O2 | 75369-40-3 | Details |
Product Total: Product Page: | ||||
60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 |